While statins are now available as generic drugs, they continue to be highly profitable. The core belief (dogma) around their use has remained largely unchanged since their introduction, despite the increasing amount of questionable literature on the subject. Moreover, the threshold for LDL cholesterol testing has been deliberately lowered periodically, which leads to more people being prescribed statins. Statins have been linked to various health issues, including diabetes, sarcopenia, liver damage, dementia, fatigue and other chronic conditions. It's important to note that, in many cases, it’s not just the prescription of drugs that drives profitability, it’s also the consultations and government subsidies that accompany them. Pharmaceutical companies continue to earn substantial revenue, and even as generics flood the market, branded versions of statins remain profitable due to brand loyalty, aggressive marketing, and physician endorsements. If you're still unsure, I encourage you to ask your physician friends about it. And remember, they have no drug for triglycerides, which is the real marker for cardiovascular risk.
